BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Keloids Scars

Below is an extended Keloids Scars research listing. Click here to return to the Keloids Scars main in depth entry.

Recent Publications on Keloids Scars:

Adenoviral Overexpression and Small Interfering RNA Suppression Demonstrate That Plasminogen Activator Inhibitor-1 Produces Elevated Collagen Accumulation in Normal and Keloid Fibroblasts.
Keloids are tumor-like skin scars that grow as a result of the aberrant...
Direct Link
4th October, 2008
From The Saban Research Institute of Childrens Hospital,* Los Angeles,
Corneal keloid. 2nd October, 2008
From the Cornea Services and Ocular Pathology, Dr Rajendra Prasad Centre
Skin of color education in dermatology residency programs: does residency training reflect the changing demographics of the United States?
BACKGROUND: It is projected that by the year 2050, close to 50% of the US...
Direct Link
1st October, 2008
Department of Dermatology and Cutaneous Surgery at University of Miami
Keloids as a serious disease such as malignancy.
Hypertrophic scar and keloids are fibroproliferative disorders of the skin...
Direct Link
20th September, 2008
An Open, Randomized, Controlled, Comparative Study of the Combined Effect of Intralesional Triamcinolone Acetonide and Onion Extract Gel and Intralesional Triamcinolone Acetonide Alone in the Treatment of Hypertrophic Scars and Keloids.
BACKGROUND Various treatment regimens have been used in scars. The...
Direct Link
19th September, 2008
Department of Dermatology, School of Medicine Etlik, Gulhane Military
Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. 18th September, 2008
Department of Pharmacology and Clinical Pharmacology, Christian Medical
Nodular scleroderma: a report of 2 cases.
Nodular scleroderma, also known as keloidal scleroderma, is a rare form of...
Direct Link
10th September, 2008
Division of Dermatopathology, Department of Dermatology, Hospital of the
Gene expression profiling reveals alteration of caspase 6 and 14 transcripts in normal skin of keloid-prone patients.
Excessive scar formation in keloids points to altered tissue modeling and...
Direct Link
3rd September, 2008
Department of Pathology, Laboratory Medicine, Indiana University School of
Intralesional cryosurgery for the treatment of hypertrophic scars and keloids following aesthetic surgery: the results of a prospective observational study.
Hypertrophic scars and keloids following aesthetic surgery, which ignite...
Direct Link
2nd September, 2008
The Bruce Rappaport Faculty of Medicine, Unit of Plastic Surgery, Carmel
Antimitotic drug injections and radiotherapy: a review of the effectiveness of treatment for hypertrophic scars and keloids.
Scars are a common complication of surgery or burn wound management. Scars...
Direct Link
2nd September, 2008
Institute of Burn, Ruijin Hospital, Jiaotong University Medical School,
Standard guidelines of care: CO 2 laser for removal of benign skin lesions and resurfacing. 21st August, 2008
Department of Dermatology, Manipal Hospital, Bangalore, India.
Standard guidelines of care for chemical peels. 21st August, 2008
Department of Dermatology, Safdarjung Hospital, New Delhi, India.
[Variations of lipid peroxidation products and copper, zinc-superoxide dismutase in pathological scars] 7th August, 2008
Department of Plastic and Burn Surgery, West China Hospital, Sichuan
Prevention and management of hypertrophic scars and keloids after burns in children.
Hypertrophic scars and keloids are challenging to manage, particularly as...
Direct Link
25th July, 2008
Department of Dermatology and Cutaneous Surgery, University of Miami,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional